VOLU SOL INC
NT 10-K, NT 10-Q, 2000-12-29
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: HYPERCOM CORP, 8-K, EX-10.B, 2000-12-29
Next: EVERGREEN INTERNATIONAL TRUST, NSAR-B, 2000-12-29




                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25
                           NOTIFICATION OF LATE FILING

(Check one): _X__  Form 10-KSB __ Form 20-F __ Form 10-QSB __ Form N-SAR


            For period ended: September 30, 2000

            [ ]  Transition  Report on Form 10-K and Form 10-KSB
            [ ]  Transition  Report  on  Form  20-F
            [ ]  Transition  Report  on  Form  11-K
            [ ]  Transition Report on Form 10-Q and Form 10-QSB
            [ ] Transition Report on Form N-SAR
            For the transition period ended

SEC File Number 0-23153

CUSIP Number -

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the          item(s)          to         which         the          notification
relates:_________________________________________

                          PART I-REGISTRANT INFORMATION

VOLU-SOL, INC.
--------------------------------------
Full Name of Registrant

5099 West 2100 South
Salt Lake City, Utah 84120
(801) 974-9474
--------------------------------------
Address and telephone number of
principal executive office

                         PART II-RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or


                                       1

<PAGE>

expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box)

[ ]         (a) The  reasons described in  reasonable detail in Part III of this
            form could not be eliminated without unreasonable effort or expense;

[X]         (b) The subject annual report, semi-annual report, transition report
            on Forms 10-K, 10-KSB, 20-F, 11-K, or Form N-SAR, or portion thereof
            will be filed on or  before  the 15th  calendar  day  following  the
            prescribed due date; or the subject  quarterly  report or transition
            report on Form 10-Q,  10-QSB, or portion thereof will be filed on or
            before the fifth calendar day following the prescribed due date; and

[ ]         (c) The  accountant's  statement or  other exhibit  required by Rule
            12b-25(c) has been attached if applicable.

                               PART III-NARRATIVE

      State below in  reasonable  detail the reasons why the Form 10-K,  10-KSB,
11-K, 20-F 10-Q, 10-QSB,  N-SAR or the transition report portion thereof,  could
not be filed within the prescribed time period.

      The annual  report of the  registrant  on Form  10-KSB  could not be filed
      because  of delays  encountered  in  finalizing  the  financial  and other
      information needed to complete the report.

                            PART IV-OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this
      notification.

Michael Acton               (801)            974-9474
   (Name)                 (Area Code)    (Telephone Number)

(2)   Have all other periodic  reports required under Section 13 or 15(d) or the
      Securities  Exchange Act of 1934 or Section 30 of the  Investment  Company
      Act of 1940 during the  preceding  12 months (or for such  shorter  period
      that the registrant was required to file such  report(s))  been filed?  If
      the answer is no, identify report(s).

                                          X  Yes    __ No

(3)   Is it  anticipated  that any  significant  change in results of operations
      from the corresponding period for the last fiscal year will be


                                       2

<PAGE>

      reflected by the earnings statements to be included in the subject
      report or portion thereof?

                                          __ Yes       X  No

            If so:  attach  an  explanation  of  the  anticipated  change,  both
            narratively  and  quantitatively,  and,  if  appropriate,  state the
            reasons why a reasonable estimate of the results cannot be made.


                                  VOLU-SOL, INC
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.



Date   December 29, 2000           By:   /s/ Michael G. Acton
                                      ---------------------------------
                                      Michael G. Acton, Chief Accounting Officer



                                       3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission